Our group first demonstrated that pharmacologic targeting NAE rehabilitated T cells derived from patients with chronic lymphocytic leukemia (CLL), leading to decreased Treg differentiation and enhanced TH1 polarization, accompanied by increased production of interferon-γ (IFN-γ), and confirmed these findings in immunized mice [21]. This evidence concerns the gene IFNG and B-cell chronic lymphocytic leukemia.